These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 23092187)

  • 21. Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.
    Erramuzpe A; Cortés JM; López JI
    Virchows Arch; 2018 Feb; 472(2):187-194. PubMed ID: 28842744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CancerTracer: a curated database for intrapatient tumor heterogeneity.
    Wang C; Yang J; Luo H; Wang K; Wang Y; Xiao ZX; Tao X; Jiang H; Cai H
    Nucleic Acids Res; 2020 Jan; 48(D1):D797-D806. PubMed ID: 31701131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.
    Lucas CH; Mirchia K; Seo K; Najem H; Chen W; Zakimi N; Choudhury A; Liu SJ; Phillips J; Magill S; Horbinski C; Solomon D; Perry A; Vasudevan H; Heimberger A; Raleigh D
    Res Sq; 2023 May; ():. PubMed ID: 37292686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
    McGranahan N; Swanton C
    Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of intertumor and intratumor heterogeneity in liver cancer.
    Liu J; Dang H; Wang XW
    Exp Mol Med; 2018 Jan; 50(1):e416. PubMed ID: 29303512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
    Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
    Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
    Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
    Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary dynamics of intratumor heterogeneity.
    Iwasa Y; Michor F
    PLoS One; 2011 Mar; 6(3):e17866. PubMed ID: 21479218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering intratumor heterogeneity: the next frontier for pathologists.
    López JI; De Petris G
    Pathologica; 2017 Jun; 109(2):110-113. PubMed ID: 28748969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.
    Rehemtulla A
    Neoplasia; 2012 Dec; 14(12):1278-89. PubMed ID: 23308059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathology in real time.
    Ryška A
    Cancer Metastasis Rev; 2016 Mar; 35(1):129-40. PubMed ID: 26931654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor heterogeneity and circulating tumor cells.
    Zhang C; Guan Y; Sun Y; Ai D; Guo Q
    Cancer Lett; 2016 May; 374(2):216-23. PubMed ID: 26902424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell sorting in cancer research--diminishing degree of cell heterogeneity.
    Barteneva NS; Ketman K; Fasler-Kan E; Potashnikova D; Vorobjev IA
    Biochim Biophys Acta; 2013 Aug; 1836(1):105-22. PubMed ID: 23481260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal cooperativity in heterogenous cancers.
    Zhou H; Neelakantan D; Ford HL
    Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Heterogeneity: Will It Change What Pathologists Do.
    Bosman FT
    Pathobiology; 2018; 85(1-2):18-22. PubMed ID: 28482346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.